DCOY
Decoy Therapeutics Inc.
NASDAQ: DCOY · HEALTHCARE · BIOTECHNOLOGY
$5.54
+1.19% today
Updated 2026-04-29
Market cap
$2.89M
P/E ratio
—
P/S ratio
15.86x
EPS (TTM)
$-129.10
Dividend yield
—
52W range
$5 – $239
Volume
0.1M
Decoy Therapeutics Inc. (DCOY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.01M | $1.27M | $838142.00 | $3.47M | $5.23M | $1.84M | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | +26.1% | -34.2% | +313.4% | +51.0% | -64.8% | -100.0% | — | — | — |
| Cost of revenue | $11997.00 | $49881.00 | $662747.00 | $506530.00 | $430750.00 | — | — | $19183.00 | $6677.00 | $10051.00 | $4424.00 | $8.52M |
| Gross profit | $-11997.00 | $-49881.00 | $347916.00 | $767969.00 | $407392.00 | $3.47M | $5.23M | $1.82M | $-6677.00 | $-10051.00 | $-4424.00 | $-8.52M |
| Gross margin | — | — | 34.4% | 60.3% | 48.6% | 100.0% | 100.0% | 99.0% | — | — | — | — |
| R&D | $4.00M | $12.75M | $20.38M | $16.99M | $11.91M | $4.02M | $6.91M | $8.55M | $15.84M | $7.17M | $770027.00 | $368170.00 |
| SG&A | — | — | — | — | — | $7.71M | $6.11M | $6.10M | $7.14M | $5.72M | $4.96M | $3.73M |
| Operating income | $-8.03M | $-29.21M | $-39.89M | $-34.73M | $-22.07M | $-8.27M | $-7.79M | $-12.81M | $-31.84M | $-12.89M | $-5.73M | $-12.61M |
| Operating margin | — | — | -3946.5% | -2724.6% | -2633.7% | -238.5% | -148.8% | -696.3% | — | — | — | — |
| EBITDA | $-8.00M | $-29.09M | $-39.61M | $-34.40M | $-21.85M | $-8.14M | $-7.59M | $-12.79M | $-22.97M | $-12.88M | $-5.73M | $-12.61M |
| EBITDA margin | — | — | -3919.1% | -2699.2% | -2606.5% | -234.8% | -145.1% | -695.2% | — | — | — | — |
| EBIT | $-8.01M | $-29.14M | $-39.89M | $-34.73M | $-22.07M | $-8.26M | $-7.61M | $-12.81M | $-22.98M | $-12.89M | $-5.73M | — |
| Interest expense | — | — | — | — | — | — | $3047.00 | — | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.01M | $-29.14M | $-39.49M | $-34.43M | $-21.92M | $-6.94M | $-7.35M | $-12.77M | $-31.61M | $-12.54M | $-5.58M | $-12.52M |
| Net income growth (YoY) | — | -263.8% | -35.5% | +12.8% | +36.3% | +68.4% | -6.0% | -73.7% | -147.6% | +60.3% | +55.5% | -124.5% |
| Profit margin | — | — | -3907.6% | -2701.7% | -2615.6% | -200.2% | -140.5% | -693.8% | — | — | — | — |